Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership
23 janv. 2019 19h15 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIEGE, Belgium, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Advanced Nuclear Medicine Ingredients SA (“ANMI”), a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX:TLX,...
Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership
23 janv. 2019 19h15 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIEGE, Belgium, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Advanced Nuclear Medicine Ingredients SA (“ANMI”), a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX:TLX,...
Telix Pharmaceuticals Acquires Advanced Nuclear Medicine Ingredients (ANMI) SA
26 nov. 2018 02h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, BRUSSELS and LIÈGE, Belgium, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...
Telix and ANMI Expand PSMA Imaging Partnership
14 oct. 2018 18h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE, Belgium, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
Telix Pharmaceuticals and Cardinal Health Enter into Distribution Agreement for Prostate Cancer Imaging
02 oct. 2018 20h00 HE
|
Telix Pharmaceuticals Limited
INDIANAPOLIS and COLUMBUS, Ohio, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals (US) Inc. (“Telix USA”), a subsidiary of Telix Pharmaceuticals Limited (ASX:TLX), a clinical-stage...
First Patient Imaged in Prostate Imaging Study
12 août 2018 18h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of...
Drug Master File for Prostate Imaging Product Filed with the FDA
26 mars 2018 08h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, March 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix Group”, “Company”), a clinical-stage biopharmaceutical company focused on...